Equities analysts predict that Proto Labs, Inc. (NYSE:PRLB) will report sales of $91.75 million for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Proto Labs’ earnings, with the lowest sales estimate coming in at $91.60 million and the highest estimate coming in at $91.89 million. Proto Labs posted sales of $72.35 million in the same quarter last year, which suggests a positive year over year growth rate of 26.8%. The firm is expected to report its next earnings results before the market opens on Thursday, February 8th.

According to Zacks, analysts expect that Proto Labs will report full-year sales of $91.75 million for the current fiscal year, with estimates ranging from $338.00 million to $342.20 million. For the next year, analysts forecast that the business will post sales of $438.39 million per share, with estimates ranging from $438.27 million to $438.50 million. Zacks’ sales averages are a mean average based on a survey of research firms that that provide coverage for Proto Labs.

Proto Labs (NYSE:PRLB) last released its quarterly earnings results on Thursday, October 26th. The industrial products company reported $0.56 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.04. The firm had revenue of $88.10 million during the quarter, compared to analyst estimates of $85.68 million. Proto Labs had a return on equity of 11.63% and a net margin of 14.53%. The business’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.51 EPS.

Several research firms have recently commented on PRLB. Zacks Investment Research raised Proto Labs from a “hold” rating to a “buy” rating and set a $120.00 price target for the company in a research report on Saturday, January 13th. Piper Jaffray Companies reissued a “hold” rating and issued a $84.00 price target on shares of Proto Labs in a research report on Thursday, December 14th. Craig Hallum set a $92.00 price target on Proto Labs and gave the stock a “hold” rating in a research report on Monday, November 27th. Finally, BidaskClub lowered Proto Labs from a “strong-buy” rating to a “buy” rating in a research report on Friday, October 6th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. Proto Labs currently has an average rating of “Hold” and a consensus target price of $85.25.

In other news, Director Rainer Gawlick sold 500 shares of the business’s stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $102.75, for a total value of $51,375.00. Following the completion of the transaction, the director now directly owns 10,925 shares of the company’s stock, valued at approximately $1,122,543.75. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP John B. Tumelty sold 13,556 shares of the company’s stock in a transaction dated Wednesday, November 22nd. The shares were sold at an average price of $92.07, for a total value of $1,248,100.92. The disclosure for this sale can be found here. Over the last three months, insiders sold 19,556 shares of company stock valued at $1,814,101. Corporate insiders own 7.78% of the company’s stock.

Large investors have recently made changes to their positions in the stock. Victory Capital Management Inc. increased its position in Proto Labs by 17.7% during the 2nd quarter. Victory Capital Management Inc. now owns 2,323 shares of the industrial products company’s stock valued at $156,000 after buying an additional 349 shares in the last quarter. Cubist Systematic Strategies LLC acquired a new position in Proto Labs during the 3rd quarter valued at about $238,000. Hanseatic Management Services Inc. acquired a new position in Proto Labs during the 3rd quarter valued at about $243,000. Pinebridge Investments L.P. increased its position in Proto Labs by 0.9% during the 2nd quarter. Pinebridge Investments L.P. now owns 3,212 shares of the industrial products company’s stock valued at $216,000 after buying an additional 29 shares in the last quarter. Finally, Advisor Group Inc. increased its position in Proto Labs by 3.6% during the 2nd quarter. Advisor Group Inc. now owns 3,409 shares of the industrial products company’s stock valued at $230,000 after buying an additional 119 shares in the last quarter.

Proto Labs (NYSE:PRLB) opened at $111.70 on Friday. The company has a market capitalization of $2,980.00, a price-to-earnings ratio of 63.47, a PEG ratio of 2.36 and a beta of 1.07. Proto Labs has a 1 year low of $48.00 and a 1 year high of $111.80.

ILLEGAL ACTIVITY WARNING: This report was first reported by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at https://www.watchlistnews.com/proto-labs-inc-prlb-expected-to-announce-quarterly-sales-of-91-75-million/1814799.html.

About Proto Labs

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Get a free copy of the Zacks research report on Proto Labs (PRLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.